1. JAK/STAT Signaling Stem Cell/Wnt Immunology/Inflammation Apoptosis
  2. STAT Interleukin Related TNF Receptor
  3. ER-464195-01

ER-464195-01 是一种口服有效的 CRTITGAs 结合抑制剂。ER-464195-01 通过解离 CRT 和 ITGAs 之间的结合来抑制白细胞浸润和随后的炎症级联反应。ER-464195-01 下调由 DSS (HY-116282C) 诱导的促炎基因 (例如 TNF-αIL-1βIL-6IL-17f) 的表达,并抑制 STAT3 的磷酸化和血清淀粉样蛋白 A (SAA) 的产生。ER-464195-01 可用于炎症性肠病 (IBD) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

ER-464195-01

ER-464195-01 Chemical Structure

CAS No. : 859218-37-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
5 mg ¥722
In-stock
10 mg ¥1148
In-stock
25 mg ¥2278
In-stock
50 mg ¥3638
In-stock
100 mg   询价  
200 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

ER-464195-01 is an orally active calreticulin (CRT) and integrin α subunits (ITGAs) binding inhibitor. ER-464195-01 inhibits leukocyte infiltration and subsequent inflammatory cascade reactions by dissociating the binding between CRT and ITGA. ER-464195-01 down-regulates the expression of pro-inflammatory genes (such as TNF-α, IL-1β, IL-6, IL-17f) induced by DSS (HY-116282C), and inhibit the phosphorylation of STAT3 and the production of serum amyloid A (SAA). ER-464195-01 can be used for the study of inflammatory bowel disease (IBD)[1].

IC50 & Target[1]

STAT3

 

IL-1β

 

IL-6

 

IL-17F

 

体外研究
(In Vitro)

ER-464195-01 (5 μM) 可有效抑制 Jurkat 细胞内 CRT 与 ITGA4 的相互作用,并显著降低细胞表面 CRT 的水平[1]
ER-464195-01 (0.01-10 μM,60 分钟) 可抑制 PMA (HY-18739) 刺激的 VCAM-1 细胞和 fMLP (HY-P0224) 刺激的 ICAM-1 细胞的粘附能力,IC50 值分别为 0.15 μM 和 0.19 μM,在 MnCl2 刺激下则无抑制效果[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

ER-464195-01 (5-10 mg/kg,口服,每日一次,连用 6-32 天) 通过预防和治疗给药均可改善 IBD 小鼠模型的病情严重程度[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: DSS induced IBD model established in female Balb/c mice (9- to 10-week-old)[1]
Dosage: 10 mg/kg (preventive administration) and 5 mg/kg (therapeutic administration)
Administration: Oral administration (p.o.), once daily for 6-7 days
Result: Effectively alleviated the weight loss, increased DAI, and shortened colon in mice under both administration methods.
Reduced the interaction signal between CRT and ITGA4.
Inhibited the upregulation of key pro-inflammatory cytokine mRNAs such as TNF-α, IL1-b, IL-6, and IL-17f induced by DSS.
Inhibited the phosphorylation of STAT3 (p-STAT3) induced by DSS and the production of serum amyloid A (SAA).
Animal Model: CD4+CD45RBhigh T-cell transfer model established in female Balb/c mice (6-week-old)[1]
Dosage: 10 mg/kg
Administration: Oral administration (p.o.), once daily for 32 days
Result: Significantly improved the weight loss in mice and the changes in their fecal characteristics (diarrhea).
分子量

379.02

Formula

C23H39ClN2

CAS 号
性状

固体

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
ER-464195-01
目录号:
HY-124686
需求量: